Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Tiziana Life Sciences (TLSA)

Tiziana Life Sciences Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TLSA
DateTimeSourceHeadlineSymbolCompany
20/11/201911:45Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:TLSATiziana Life Sciences Ltd
01/11/201910:06Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:TLSATiziana Life Sciences Ltd
30/10/201912:16Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:TLSATiziana Life Sciences Ltd
22/10/201916:32Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:TLSATiziana Life Sciences Ltd
08/10/201920:03Edgar (US Regulatory)Post-effective Amendment to a Previously Filed F-6. (f-6 Pos)NASDAQ:TLSATiziana Life Sciences Ltd
30/09/201912:56Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:TLSATiziana Life Sciences Ltd
20/09/201922:03Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:TLSATiziana Life Sciences Ltd
20/09/201921:52Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-1/a)NASDAQ:TLSATiziana Life Sciences Ltd
17/09/201922:20Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-1/a)NASDAQ:TLSATiziana Life Sciences Ltd
16/09/201912:44Business WireTiziana Life Sciences Announces FDA Approval to Initiate Phase I Clinical Trial with Orally Administered Foralumab in Healthy...NASDAQ:TLSATiziana Life Sciences Ltd
16/09/201912:03Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:TLSATiziana Life Sciences Ltd
10/09/201912:00Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:TLSATiziana Life Sciences Ltd
10/09/201912:00Business WireTiziana Reports Phase 1 Clinical Data Demonstrating Nasal Treatment with Foralumab was Well-tolerated & Produced Positive Tre...NASDAQ:TLSATiziana Life Sciences Ltd
04/09/201912:01Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:TLSATiziana Life Sciences Ltd
04/09/201912:00Business WireTiziana Life Sciences Reports Positive Phase 2a Clinical Data Exhibiting Positive Clinical Activity with Milciclib Monotherap...NASDAQ:TLSATiziana Life Sciences Ltd
06/08/201911:06Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:TLSATiziana Life Sciences Ltd
06/08/201911:02Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:TLSATiziana Life Sciences Ltd
05/08/201921:29Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-1)NASDAQ:TLSATiziana Life Sciences Ltd
22/07/201911:05Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:TLSATiziana Life Sciences Ltd
22/07/201907:10Business WireTiziana Reports Phase 2a Clinical Data with Milciclib Monotherapy in Sorafenib-refractory or -intolerant patients with unrese...NASDAQ:TLSATiziana Life Sciences Ltd
01/07/201912:03Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:TLSATiziana Life Sciences Ltd
01/07/201909:24Business WireTiziana Life Science reports Independent Third Party Article in New England Journal of Medicine on Intravenous Treatment with...NASDAQ:TLSATiziana Life Sciences Ltd
24/06/201918:26Business WireNewly Published Article Reporting Clinical Activity of Orally Administered OKT3, a Mouse Anti-CD3 Monoclonal Antibody, in Mod...NASDAQ:TLSATiziana Life Sciences Ltd
24/06/201912:12Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:TLSATiziana Life Sciences Ltd
03/06/201911:20Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:TLSATiziana Life Sciences Ltd
31/05/201911:37Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:TLSATiziana Life Sciences Ltd
07/05/201911:09Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:TLSATiziana Life Sciences Ltd
02/05/201911:19Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:TLSATiziana Life Sciences Ltd
01/05/201911:45Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:TLSATiziana Life Sciences Ltd
25/04/201917:10Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:TLSATiziana Life Sciences Ltd
 Showing the most relevant articles for your search:NASDAQ:TLSA